Association between T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Genetic Polymorphisms and Susceptibility to Autoimmune Diseases

References

• Anaya JM, Gomez L, Castiblanco J. (2006). Is there a common genetic basis for autoimmune diseases? Clin Dev Immunol, 13, 185–195. doi:10.1080/17402520600876762
   PubMedGoogle Scholar
• Banerjee H, Kane LP. (2018). Immune regulation by Tim-3. F1000research, 7, 316. doi:10.12688/f1000research
   PubMedGoogle Scholar
• Bruck P, Ramos-Lopez E, Bartsch W, et al. (2008). TIM-3 polymorphisms in type 1 diabetes families. J Hum Genet, 53, 559–564. doi:10.1007/s10038-008-0286-y
   PubMed Web of Science ®Google Scholar
• Chae SC, Park YR, Lee YC, et al. (2004a). The association of TIM-3 gene polymorphism with atopic disease in Korean population. Hum Immunol, 65, 1427–1431. doi:10.1016/j.humimm.2004.07.002
   PubMed Web of Science ®Google Scholar
• Chae SC, Park YR, Shim SC, et al. (2004b). The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett, 95, 91–95. doi:10.1016/j.imlet.2004.06.008
   PubMed Web of Science ®Google Scholar
• Cheng S, Ju Y, Han F, et al. (2017). T Cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to invasive breast cancer. Ann Clin Lab Sci, 47, 668–675.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Bynum ML, Somers EC. (2009). Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun, 33, 197–207. doi:10.1016/j.jaut.2009.09.008
   PubMed Web of Science ®Google Scholar
• Costenbader KH, Gay S, Alarcon-Riquelme ME, et al. (2012). Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev, 11, 604–609. doi:10.1016/j.autrev.2011.10.022
   PubMed Web of Science ®Google Scholar
• Dhaeze T, Stinissen P, Liston A, Hellings N. (2015). Humoral autoimmunity: a failure of regulatory T cells? Autoimmun Rev, 14, 735–741. doi:10.1016/j.autrev.2015.04.006
   PubMed Web of Science ®Google Scholar
• Du WT, Zhao HF, Xu JH, et al. (2009). The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Hum Immunol, 70, 398–402. doi:10.1016/j.humimm.2009.03.013
   PubMed Web of Science ®Google Scholar
• Edwards M, Dai R, Ahmed SA. (2018). Our environment shapes us: the importance of environment and sex differences in regulation of autoantibody production. Front Immunol, 9, 478. doi:10.3389/fimmu.2018.00478
   PubMed Web of Science ®Google Scholar
• Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. (2010). TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev, 235, 172–189. doi:10.1111/j.0105-2896.2010.00903.x
   PubMed Web of Science ®Google Scholar
• Gao H, Peng CM, Fu XY, et al. (2015). Association analysis of Tim-3-1516G>T polymorphism with systemic lupus erythematosus in a han population of Yun-nan Province. Lab Med Clin, 12, 1034–1036.
   Google Scholar
• Garcia-Lozano JR, Abad C, Escalera A, et al. (2010). Identification of HAVCR1 gene haplotypes associated with mRNA expression levels and susceptibility to autoimmune diseases. Hum Genet, 128, 221–229. doi:10.1007/s00439-010-0844-1
   PubMed Web of Science ®Google Scholar
• Generali E, Ceribelli A, Stazi MA, Selmi C. (2017). Lessons learned from twins in autoimmune and chronic inflammatory diseases. J Autoimmun, 83, 51–61. doi:10.1016/j.jaut.2017.04.005
   PubMed Web of Science ®Google Scholar
• Grant CR, Liberal R, Mieli-Vergani G, et al. (2015). Regulatory T-cells in autoimmune diseases: challenges, controversies and–yet–unanswered questions. Autoimmun Rev, 14, 105–116. doi:10.1016/j.autrev.2014.10.012
   PubMed Web of Science ®Google Scholar
• Han G, Chen G, Shen B, Li Y. (2013). Tim-3: an activation marker and activation limiter of innate immune cells. Front Immunol, 4, 449. doi:10.3389/fimmu.2013.00449
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539–1558. doi:10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557–560. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Jiang F, Li S, Jia C. (2015). Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis. Clin Rheumatol, 34, 1885–1892. doi:10.1007/s10067-015-3008-9
   PubMed Web of Science ®Google Scholar
• Kamradt T, Mitchison NA. (2001). Tolerance and autoimmunity. N Engl J Med, 344, 655–664. doi:10.1056/NEJM200103013440907
   PubMed Web of Science ®Google Scholar
• Kavvoura FK, Ioannidis JP. (2008). Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet, 123, 1–14. doi:10.1007/s00439-007-0445-9
   PubMed Web of Science ®Google Scholar
• Lee SY, Goverman JM. (2013). The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells. J Immunol, 190, 4991–4999. doi:10.4049/jimmunol.1300083
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC. (2017). Association between functional CYP2D6 polymorphisms and susceptibility to autoimmune diseases: a meta-analysis. Immunol Invest, 46, 109–122. doi:10.1080/08820139.2016.1226898
   PubMed Web of Science ®Google Scholar
• Li S, Zhang Q, Wang P, et al. (2018). Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Immunol Invest, 47, 101–112. doi:10.1080/08820139.2017.1385622
   PubMed Web of Science ®Google Scholar
• Li WX, Chen GM, Yuan H, et al. (2011). Polymorphisms of the TIM-1 and TIM-3 genes are not associated with systemic lupus erythematosus in a Chinese population. Mutagenesis, 26, 507–511. doi:10.1093/mutage/ger009
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Zhang J, et al. (2010). Asthma susceptible genes in Chinese population: a meta-analysis. Respir Res, 11, 129. doi:10.1186/1465-9921-11-62
   PubMed Web of Science ®Google Scholar
• Li X, Zhao YQ, Li CW, Yuan F-L. (2012). T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis. Expert Opin Ther Targets, 16, 1145–1149. doi:10.1517/14728222.2012.726616
   PubMed Web of Science ®Google Scholar
• Li Z, Li N, Li F, et al. (2016). Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma. Medicine (Baltimore), 95, e5749. doi:10.1097/MD.0000000000004864
   PubMed Web of Science ®Google Scholar
• Li Z, Li N, Zhu Q, et al. (2013). Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection. Infect Genet Evol, 14, 240–246. doi:10.1016/j.meegid.2012.12.008
   PubMed Web of Science ®Google Scholar
• Liang T, Wang XB, Cai PC, et al. (2012). Polymorphisms of the T-cell immunoglobulin and mucin domain molecule-3 are not associated with autoimmune Graves‘ disease in a Chinese Han Population. Clin Biochem, 45, 1624–1628. doi:10.1016/j.clinbiochem.2012.08.004
   PubMed Web of Science ®Google Scholar
• Lin DP, Xue ZX, Cai ZZ, et al. (2017). Relationship between gene polymorphisms of T cell immunoglobulin domain and mucin domain protein-3 and ulcerative colitis. Chin J Dig, 37, 612–618.
   Google Scholar
• Mazrouei F, Ganjalikhani-Hakemi M, Salehi R, et al. (2016). Association of TIM-1 5383-5397ins/del and TIM-3-1541C>T polymorphisms with multiple sclerosis in Isfahan population. Int J Immunogenet, 43, 131–134. doi:10.1111/iji.12264
   PubMed Web of Science ®Google Scholar
• Monney L, Sabatos CA, Gaglia JL, et al. (2002). Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature, 415, 536–541. doi:10.1038/415536a
   PubMed Web of Science ®Google Scholar
• Ocana-Guzman R, Torre-Bouscoulet L, Sada-Ovalle I. (2016). TIM-3 regulates distinct functions in macrophages. Front Immunol, 7, 229. doi:10.3389/fimmu.2016.00229
   PubMed Web of Science ®Google Scholar
• Pouladian M, Ganjalikhani-Hakemi M, Alsahebfosul F, et al. (2017). The +4259A>C polymorphism of TIM-3 but not −1637C>T polymorphism of TIM-1 is associated with Multiple sclerosis in Isfahan population. Mult Scler Relat Disord, 18, 152–156. doi:10.1016/j.msard.2017.09.031
   PubMed Web of Science ®Google Scholar
• Radwan ER, Youssef EA, Sewelam NI, et al. (2014). Study of T-cell immunoglobulin- and mucin-domain-containing molecule 3 polymorphisms in Egyptian childhood immune thrombocytopenic purpura. Comp Clin Path, 23, 933–939. doi:10.1007/s00580-013-1716-6
   Google Scholar
• Sanchez-Fueyo A, Tian J, Picarella D, et al. (2003). Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol, 4, 1093–1101. doi:10.1038/ni987
   PubMed Web of Science ®Google Scholar
• Seki M, Oomizu S, Sakata KM, et al. (2008). Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol, 127, 78–88. doi:10.1016/j.clim.2008.01.006
   PubMed Web of Science ®Google Scholar
• Song YW, Im CH, Park JH, et al. (2011). T-cell immunoglobulin and mucin domain 3 genetic polymorphisms are associated with rheumatoid arthritis independent of a shared epitope status. Hum Immunol, 72, 652–655. doi:10.1016/j.humimm.2011.04.007
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Clements JA, Batra J. (2016). Single nucleotide polymorphisms in clinics: fantasy or reality for cancer? Crit Rev Clin Lab Sci, 53, 29–39. doi:10.3109/10408363.2015.1075469
   PubMed Web of Science ®Google Scholar
• Sun L, Wu H, Cao SG, et al. (2017). Association of Crohn‘s disease with T cell immunoglobulin and mucin domain 3 gene polymorphisms in Chinese patients. Zhonghua Nei Ke Za Zhi, 56, 667–672. doi:10.3760/cma.j.issn.0578-1426.2017.09.009
   PubMedGoogle Scholar
• Wang L, Wang FS, Gershwin ME. (2015). Human autoimmune diseases: a comprehensive update. J Intern Med, 278, 369–395. doi:10.1111/joim.12395
   PubMed Web of Science ®Google Scholar
• Wang MF, Ji B, Wang J, et al. (2014). Tim-3 polymorphism downregulates gene expression and is involved in the susceptibility to ankylosing spondylitis. DNA Cell Biol, 33, 723–728. doi:10.1089/dna.2014.2456
   PubMed Web of Science ®Google Scholar
• Wang XX, Chen T. (2018). Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk. Immunol Invest, 47, 431–442. doi:10.1080/08820139.2018.1425699
   PubMed Web of Science ®Google Scholar
• Xu GW, Zheng K, Lu X, et al. (2015). Association between polymorphisms in the promoter region of T cell immunoglobulin and mucin domain-3 and myasthenia gravis-associated thymoma. Oncol Lett, 9, 1470–1474. doi:10.3892/ol.2015.2845
   PubMed Web of Science ®Google Scholar
• Xu J, Yang Y, Liu X, Wang Y. (2011). The −1541 C>T and +4259 G>T of TIM-3 polymorphisms are associated with rheumatoid arthritis susceptibility in a Chinese Hui population. Int J Immunogenet, 38, 513–518. doi:10.1111/j.1744-313X.2011.01046.x
   PubMed Web of Science ®Google Scholar
• Yaghoobi E, Abedian S, Babani O, Izad M. (2016). TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) gene polymorphisms and risk of multiple sclerosis. Iran J Public Health, 45, 644–649.
   PubMed Web of Science ®Google Scholar
• Zhang CC, Wu JM, Cui TP, et al. (2005). Study on the relation between polymorphism sites of Tim-3 promoter region and rheumatoid arthritis in Han adult population from Hubei Province of China. Chin J Rheumatol, 9, 526–529.
   Google Scholar
• Zhang CC, Wu JM, Cui TP, et al. (2006). Association between Tim-3 genetic polymorphism and rheumatoid arthritis in Han Chinese from Hubei Province of China. Chin J Microbiol Immunol, 26, 55.
   Google Scholar
• Zhang XM, Shan NN. (2014). The role of T cell immunoglobulin and mucin domain-3 in immune thrombocytopenia. Scand J Immunol, 79, 231–236. doi:10.1111/sji.12153
   PubMed Web of Science ®Google Scholar